Additionally, research on PCSK9 inhibitors and malignant tumors has shown varying associations, with negative correlations observed with breast and lung cancer, but positive correlations with gastric, liver, oral, pharyngeal, and cervical cancers [30]. Here, PCSK9 is linked to lung carcinoma.